BioCryst Pharmaceuticals
BCRX
BCRX
109 hedge funds and large institutions have $156M invested in BioCryst Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 27 closing their positions.
Holders
109
Holders Change
-9
Holders Change %
-7.63%
% of All Funds
2.91%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
42
Reduced
26
Closed
27
Calls
$167K
Puts
$92K
Net Calls
+$75K
Net Calls Change
+$74K
Top Buyers
| 1 |
VMI
1
VHCP Management II
New York
|
$13.3M |
| 2 |
2
D.E. Shaw & Co
New York
|
$11.5M |
| 3 |
BBA
3
Baker Bros. Advisors
New York
|
$42.5M |
| 4 |
VM
4
VHCP Management
New York
|
$1.59M |
| 5 |
SIM
5
Spark Investment Management
New York
|
$1.5M |
